Altria Group, Inc.
MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/304% above fair value
$77.17−0.86 (-1.10%)
Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%
Altria FDA User Fees — Oral Tobacco Products by Quarter
FDA User Fees — Oral Tobacco Products ($M) ($M)
Altria FDA User Fees — Oral Tobacco Products: $1M in Q3 2026, down 50.0% from a year earlier. That is the lowest of the 48 quarters on record here.
Latest, Q3 2026
1
Period ended Sep 30, 2026
Change on a year earlier
-50.0%
2 in Q3 2025
History
48 quarters
Since Q4 2014
Sources
44
Documents cited below
Where the Q3 2026 figure comes from
“|| Oral tobacco products | 1 | 2 | 4 | 4”
Source: Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000112), filed 2026-10-29 ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Altria FDA User Fees — Oral Tobacco Products ($M), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/fda-fees-oral
See every metric in the Altria KPI table. Data updated Nov 2, 2026.